Cargando…

Hemorrhage of brain metastasis is a poor prognostic factor in hepatocellular carcinoma patients

It is unclear whether hemorrhage of brain metastasis is a poor prognostic factor in patients with hepatocellular carcinoma. We conducted a retrospective cohort study to compare overall survival between hemorrhage and no-hemorrhage groups of hepatocellular carcinoma patients with brain metastasis. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yan, Huang, Shi-Ting, Jiang, Yan-Ming, Pan, Xin-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696260/ https://www.ncbi.nlm.nih.gov/pubmed/29190994 http://dx.doi.org/10.18632/oncotarget.21449

Ejemplares similares

Intraparenchymal Hemorrhage due to Brain Metastasis of Hepatocellular Carcinoma
por: Sartori Balbinot, Rafael, et al.
Publicado: (2017)

Concomitant Subdural Hemorrhage and Intracerebral Hemorrhage due to Brain Metastasis of the Hepatocellular Carcinoma
por: Jang, Se Youn, et al.
Publicado: (2015)

The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma
por: Jiang, Yan-Ming, et al.
Publicado: (2023)

Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2016)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021)

Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells
por: Shi, Kaishun, et al.
Publicado: (2018)

Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2016)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
por: Luo, Yuan‐Deng, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database
por: Lin, Yan, et al.
Publicado: (2020)

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
por: Hu, Chuan, et al.
Publicado: (2020)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor
por: Han, Moon-Soo, et al.
Publicado: (2013)

Study on the hepatocellular carcinoma model with metastasis
por: Lin, Yu-Lin, et al.
Publicado: (2020)

Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2022)

Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis
por: Long, Hai-Yi, et al.
Publicado: (2021)

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
por: Li, J, et al.
Publicado: (2014)

Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma
por: Dai, Yi-Fang, et al.
Publicado: (2018)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma
por: Liang, Yuelong, et al.
Publicado: (2017)

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2019)

Retroperitoneal Hemorrhage from Adrenocortical Carcinoma as a Poor Prognostic Factor
por: Kasperlik-Zaluska, Anna A., et al.
Publicado: (2008)

MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Gamma Knife Surgery for Brain Metastasis from Hepatocellular Carcinoma
por: Xu, Qingsheng, et al.
Publicado: (2014)

Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
por: Ling, Yi-hong, et al.
Publicado: (2020)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Integrative Analysis Identifies Cell-Type-Specific Genes Within Tumor Microenvironment as Prognostic Indicators in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2022)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
por: Ma, Jia-Lin, et al.
Publicado: (2021)

Risk Factors for Brain Metastasis of Hepatocellular Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Efficacy of Surgical Resection for Pulmonary Metastases from Hepatocellular Carcinoma
por: Zhou, Yan-Ming, et al.
Publicado: (2014)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival
por: Zhang, Xin-yue, et al.
Publicado: (2023)

FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma
por: Wang, Feifei, et al.
Publicado: (2013)

Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2017)

Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma
por: Li, Xian-Peng, et al.
Publicado: (2015)

Isolated Intracardiac Metastasis: The First Sign of Hepatocellular Carcinoma
por: Paixão, Anusca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k675ps6dlq54dg6boi4ho6f4ip